Risk of diabetes mellitus associated with disease-modifying antirheumatic drugs and statins in rheumatoid arthritis

Ozen, Gulsen; Pedro, Sofia; Holmqvist, Marie; Avery, Michael; Wolfe, Frederick; Michaud, Kaleb

doi:10.1136/annrheumdis-2016-209954

Risk of diabetes mellitus associated with disease-modifying antirheumatic drugs and statins in rheumatoid arthritis

Atıf İçin Kopyala

Ozen G., Pedro S., Holmqvist M. E., Avery M., Wolfe F., Michaud K.

ANNALS OF THE RHEUMATIC DISEASES, cilt.76, sa.5, 2017 (SCI-Expanded)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 76 Sayı: 5
Basım Tarihi: 2017
Doi Numarası: 10.1136/annrheumdis-2016-209954
Dergi Adı: ANNALS OF THE RHEUMATIC DISEASES
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Marmara Üniversitesi Adresli: Hayır

Özet

Objective To investigate the rate of incident diabetes mellitus (DM) in patients with rheumatoid arthritis (RA) and the impact of disease-modifying antirheumatic drug (DMARD) and statin treatments.